Alyeska Investment Group, L.P. Boston Scientific Corp Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Boston Scientific Corp stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,641,434 shares of BSX stock, worth $172 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
1,641,434
Previous 370,000
343.63%
Holding current value
$172 Million
Previous $31 Million
372.85%
% of portfolio
0.59%
Previous 0.17%
Shares
8 transactions
Others Institutions Holding BSX
# of Institutions
1,663Shares Held
1.22BCall Options Held
8.76MPut Options Held
9.42M-
Vanguard Group Inc Valley Forge, PA133MShares$13.9 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.2 Billion0.22% of portfolio
-
State Street Corp Boston, MA64MShares$6.68 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.86 Billion2.61% of portfolio
-
Wellington Management Group LLP Boston, MA36.2MShares$3.78 Billion0.61% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $150B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...